| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Streptococcus pyogenes | 58 | 2023 | 292 | 13.090 |
Why?
|
| Streptococcal Infections | 48 | 2022 | 617 | 5.390 |
Why?
|
| Streptococcus agalactiae | 51 | 2022 | 337 | 5.040 |
Why?
|
| NAD+ Nucleosidase | 11 | 2023 | 43 | 4.080 |
Why?
|
| Streptolysins | 19 | 2021 | 57 | 3.990 |
Why?
|
| Bacterial Proteins | 49 | 2023 | 3847 | 3.390 |
Why?
|
| Gene Expression Regulation, Bacterial | 21 | 2021 | 1133 | 3.140 |
Why?
|
| Polysaccharides, Bacterial | 39 | 2019 | 578 | 2.750 |
Why?
|
| Bacterial Capsules | 25 | 2019 | 244 | 2.470 |
Why?
|
| Hyaluronic Acid | 19 | 2019 | 483 | 1.960 |
Why?
|
| Protein Kinases | 8 | 2021 | 1608 | 1.940 |
Why?
|
| Keratinocytes | 16 | 2021 | 791 | 1.730 |
Why?
|
| Virulence | 33 | 2021 | 1303 | 1.540 |
Why?
|
| Bacterial Adhesion | 8 | 2021 | 306 | 1.510 |
Why?
|
| Bacterial Outer Membrane Proteins | 9 | 2019 | 406 | 1.340 |
Why?
|
| Regulon | 3 | 2021 | 71 | 1.320 |
Why?
|
| Antigens, Bacterial | 15 | 2019 | 1154 | 1.270 |
Why?
|
| Cathelicidins | 5 | 2021 | 80 | 1.250 |
Why?
|
| Virulence Factors | 8 | 2019 | 513 | 1.030 |
Why?
|
| Genes, Bacterial | 17 | 2007 | 1073 | 0.960 |
Why?
|
| Adhesins, Bacterial | 3 | 2013 | 118 | 0.870 |
Why?
|
| Pharyngitis | 5 | 2013 | 220 | 0.870 |
Why?
|
| Repressor Proteins | 5 | 2021 | 2986 | 0.850 |
Why?
|
| Oropharynx | 2 | 2021 | 138 | 0.790 |
Why?
|
| DNA Restriction-Modification Enzymes | 1 | 2021 | 11 | 0.770 |
Why?
|
| Transformation, Genetic | 1 | 2021 | 192 | 0.740 |
Why?
|
| Antimicrobial Cationic Peptides | 5 | 2021 | 353 | 0.700 |
Why?
|
| Antibodies, Bacterial | 16 | 2000 | 1469 | 0.690 |
Why?
|
| Carrier Proteins | 11 | 2019 | 4937 | 0.680 |
Why?
|
| Bacterial Vaccines | 11 | 1999 | 401 | 0.670 |
Why?
|
| NAD | 2 | 2022 | 614 | 0.670 |
Why?
|
| Phagocytosis | 25 | 2014 | 1528 | 0.660 |
Why?
|
| Bacterial Toxins | 9 | 2021 | 932 | 0.660 |
Why?
|
| Tetanus Toxoid | 9 | 1999 | 189 | 0.600 |
Why?
|
| Epithelial Cells | 6 | 2016 | 3677 | 0.560 |
Why?
|
| Magnesium | 3 | 2021 | 804 | 0.540 |
Why?
|
| Operon | 5 | 2017 | 372 | 0.520 |
Why?
|
| Clindamycin | 4 | 2015 | 139 | 0.520 |
Why?
|
| Pharynx | 6 | 2013 | 432 | 0.510 |
Why?
|
| Skin Diseases, Bacterial | 2 | 2015 | 68 | 0.500 |
Why?
|
| Diphtheria-Tetanus-acellular Pertussis Vaccines | 1 | 2015 | 38 | 0.470 |
Why?
|
| Whooping Cough | 1 | 2015 | 86 | 0.460 |
Why?
|
| Opsonin Proteins | 8 | 1999 | 144 | 0.450 |
Why?
|
| Cellulitis | 2 | 2015 | 209 | 0.440 |
Why?
|
| Azithromycin | 1 | 2015 | 199 | 0.440 |
Why?
|
| Phagosomes | 1 | 2014 | 199 | 0.430 |
Why?
|
| Bacteremia | 4 | 2015 | 980 | 0.420 |
Why?
|
| Abscess | 2 | 2015 | 606 | 0.410 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2006 | 4352 | 0.390 |
Why?
|
| Microbial Viability | 2 | 2013 | 238 | 0.380 |
Why?
|
| Penicillin G | 1 | 2011 | 40 | 0.380 |
Why?
|
| Cough | 1 | 2015 | 594 | 0.370 |
Why?
|
| Exotoxins | 3 | 2016 | 121 | 0.340 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2015 | 637 | 0.340 |
Why?
|
| Clathrin | 1 | 2011 | 257 | 0.330 |
Why?
|
| Cytotoxins | 2 | 2022 | 153 | 0.330 |
Why?
|
| Trans-Activators | 1 | 2019 | 2856 | 0.330 |
Why?
|
| Macrophages | 7 | 2023 | 5767 | 0.330 |
Why?
|
| Anti-Bacterial Agents | 9 | 2022 | 7406 | 0.330 |
Why?
|
| Fetal Blood | 2 | 2006 | 1347 | 0.310 |
Why?
|
| Fasciitis, Necrotizing | 4 | 2018 | 79 | 0.310 |
Why?
|
| Complement C3 | 5 | 2003 | 435 | 0.300 |
Why?
|
| Protein Binding | 6 | 2021 | 9353 | 0.300 |
Why?
|
| Molecular Sequence Data | 24 | 2014 | 17635 | 0.290 |
Why?
|
| Complement System Proteins | 2 | 2003 | 735 | 0.290 |
Why?
|
| Monocytes | 3 | 2006 | 2570 | 0.290 |
Why?
|
| Toll-Like Receptors | 4 | 2006 | 589 | 0.280 |
Why?
|
| Receptor, Adenosine A3 | 1 | 2006 | 4 | 0.280 |
Why?
|
| Transferases | 2 | 1998 | 72 | 0.270 |
Why?
|
| Cell Line | 8 | 2021 | 15601 | 0.270 |
Why?
|
| Carbohydrate Sequence | 13 | 2005 | 411 | 0.270 |
Why?
|
| Protein Transport | 3 | 2021 | 1967 | 0.260 |
Why?
|
| Glycosyltransferases | 2 | 1998 | 116 | 0.260 |
Why?
|
| Rheumatic Fever | 1 | 2006 | 73 | 0.250 |
Why?
|
| Lysosomes | 2 | 2016 | 924 | 0.250 |
Why?
|
| Toll-Like Receptor 8 | 1 | 2006 | 99 | 0.250 |
Why?
|
| Disease Outbreaks | 1 | 2015 | 1749 | 0.250 |
Why?
|
| Cells, Cultured | 11 | 2019 | 18966 | 0.250 |
Why?
|
| Autophagy | 1 | 2013 | 1327 | 0.250 |
Why?
|
| Phosphorylation | 5 | 2021 | 8321 | 0.240 |
Why?
|
| Promoter Regions, Genetic | 4 | 2021 | 5790 | 0.240 |
Why?
|
| Aminoquinolines | 1 | 2004 | 107 | 0.230 |
Why?
|
| Serotyping | 8 | 2006 | 325 | 0.230 |
Why?
|
| Humans | 84 | 2024 | 761596 | 0.230 |
Why?
|
| Immunoglobulin G | 9 | 2006 | 4544 | 0.220 |
Why?
|
| Down-Regulation | 1 | 2011 | 2919 | 0.220 |
Why?
|
| Xenopus Proteins | 2 | 1998 | 434 | 0.220 |
Why?
|
| Oligosaccharides | 5 | 1995 | 406 | 0.220 |
Why?
|
| Models, Molecular | 4 | 2021 | 5439 | 0.220 |
Why?
|
| Sialic Acids | 4 | 1994 | 123 | 0.220 |
Why?
|
| Lipoproteins | 2 | 2006 | 881 | 0.210 |
Why?
|
| Dextran Sulfate | 1 | 2024 | 256 | 0.210 |
Why?
|
| Intracellular Membranes | 2 | 2014 | 389 | 0.210 |
Why?
|
| Sphingolipids | 1 | 2024 | 174 | 0.210 |
Why?
|
| Bacteroides fragilis | 1 | 2024 | 252 | 0.210 |
Why?
|
| Streptococcus | 2 | 1997 | 198 | 0.210 |
Why?
|
| Plasmids | 6 | 2007 | 2269 | 0.200 |
Why?
|
| Antigen-Presenting Cells | 1 | 2006 | 964 | 0.200 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 2012 | 2496 | 0.200 |
Why?
|
| Interleukin-1beta | 2 | 2019 | 999 | 0.200 |
Why?
|
| Membrane Glycoproteins | 3 | 2004 | 3701 | 0.200 |
Why?
|
| Haemophilus influenzae | 1 | 2022 | 178 | 0.200 |
Why?
|
| Meningitis, Bacterial | 2 | 2022 | 221 | 0.190 |
Why?
|
| Signal Transduction | 5 | 2018 | 23447 | 0.190 |
Why?
|
| Lipopolysaccharides | 4 | 2006 | 2206 | 0.190 |
Why?
|
| Ehrlichia chaffeensis | 1 | 2000 | 3 | 0.190 |
Why?
|
| Cloning, Molecular | 6 | 2014 | 4174 | 0.190 |
Why?
|
| Ehrlichiosis | 1 | 2000 | 28 | 0.180 |
Why?
|
| Calcium Signaling | 1 | 2005 | 733 | 0.180 |
Why?
|
| Cytosol | 2 | 2014 | 888 | 0.180 |
Why?
|
| Adjuvants, Immunologic | 1 | 2006 | 1036 | 0.180 |
Why?
|
| Glucuronosyltransferase | 2 | 1998 | 132 | 0.180 |
Why?
|
| Vaccines, Conjugate | 8 | 1999 | 328 | 0.170 |
Why?
|
| Membrane Proteins | 4 | 2013 | 7859 | 0.160 |
Why?
|
| Interleukins | 1 | 2024 | 782 | 0.160 |
Why?
|
| Complement C1q | 1 | 1999 | 93 | 0.160 |
Why?
|
| Cell Wall | 2 | 2000 | 425 | 0.160 |
Why?
|
| Vacuoles | 2 | 2013 | 228 | 0.160 |
Why?
|
| Uridine Diphosphate Glucose Dehydrogenase | 1 | 1998 | 8 | 0.160 |
Why?
|
| MAP Kinase Signaling System | 1 | 2006 | 1486 | 0.160 |
Why?
|
| Glucuronic Acid | 1 | 2019 | 150 | 0.160 |
Why?
|
| Cysteine Endopeptidases | 1 | 2001 | 551 | 0.160 |
Why?
|
| Vitamin D | 1 | 2012 | 3303 | 0.160 |
Why?
|
| N-Acylneuraminate Cytidylyltransferase | 2 | 1996 | 7 | 0.160 |
Why?
|
| Multigene Family | 2 | 2005 | 1076 | 0.160 |
Why?
|
| Biofilms | 2 | 2013 | 627 | 0.150 |
Why?
|
| Imidazoles | 1 | 2004 | 1180 | 0.150 |
Why?
|
| Mutagenesis, Insertional | 3 | 1998 | 656 | 0.150 |
Why?
|
| Mice, Inbred ICR | 4 | 2005 | 364 | 0.150 |
Why?
|
| Animals | 44 | 2024 | 168475 | 0.150 |
Why?
|
| Dendritic Cells | 1 | 2009 | 2747 | 0.150 |
Why?
|
| Neutrophils | 6 | 2018 | 3767 | 0.150 |
Why?
|
| Mutation | 14 | 2021 | 30053 | 0.150 |
Why?
|
| Receptors, Cell Surface | 2 | 2004 | 2822 | 0.150 |
Why?
|
| Peptidoglycan | 1 | 2000 | 249 | 0.150 |
Why?
|
| Up-Regulation | 3 | 2014 | 4125 | 0.150 |
Why?
|
| Glycoside Hydrolases | 2 | 1990 | 135 | 0.150 |
Why?
|
| Streptococcal Vaccines | 2 | 2009 | 44 | 0.150 |
Why?
|
| Mice | 30 | 2024 | 81539 | 0.140 |
Why?
|
| Rabbits | 13 | 1999 | 4772 | 0.140 |
Why?
|
| Amino Acid Sequence | 9 | 2014 | 13446 | 0.140 |
Why?
|
| Acetylglucosamine | 1 | 2019 | 189 | 0.140 |
Why?
|
| Cell Survival | 3 | 2016 | 5791 | 0.140 |
Why?
|
| Base Sequence | 11 | 2005 | 12441 | 0.140 |
Why?
|
| Immunologic Factors | 1 | 2006 | 1590 | 0.140 |
Why?
|
| Amino Acid Substitution | 1 | 2021 | 1739 | 0.140 |
Why?
|
| Open Reading Frames | 3 | 2013 | 815 | 0.140 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2019 | 452 | 0.140 |
Why?
|
| Chromosomes, Bacterial | 2 | 1995 | 281 | 0.140 |
Why?
|
| Facial Paralysis | 1 | 2000 | 346 | 0.130 |
Why?
|
| Receptors, Complement | 1 | 1997 | 253 | 0.130 |
Why?
|
| Host-Pathogen Interactions | 2 | 2017 | 1459 | 0.130 |
Why?
|
| Glycolipids | 1 | 1997 | 206 | 0.130 |
Why?
|
| IMP Dehydrogenase | 1 | 1995 | 33 | 0.130 |
Why?
|
| Inflammasomes | 2 | 2019 | 526 | 0.130 |
Why?
|
| Protein Stability | 1 | 2017 | 578 | 0.130 |
Why?
|
| Mutagenesis | 3 | 2012 | 1232 | 0.130 |
Why?
|
| Colitis | 1 | 2024 | 1233 | 0.130 |
Why?
|
| Recombinant Proteins | 3 | 2016 | 6534 | 0.130 |
Why?
|
| Immune Tolerance | 1 | 2004 | 2302 | 0.120 |
Why?
|
| Culture Media | 1 | 2017 | 897 | 0.120 |
Why?
|
| Extracellular Matrix | 2 | 2013 | 1726 | 0.120 |
Why?
|
| Complement C4 | 1 | 1995 | 217 | 0.120 |
Why?
|
| Intracellular Space | 1 | 2016 | 197 | 0.120 |
Why?
|
| Hemolysis | 3 | 2006 | 415 | 0.120 |
Why?
|
| Apoptosis | 3 | 2005 | 9490 | 0.120 |
Why?
|
| Adaptation, Physiological | 1 | 2021 | 1301 | 0.120 |
Why?
|
| Protein Multimerization | 1 | 2019 | 983 | 0.110 |
Why?
|
| Lactococcus lactis | 1 | 2013 | 29 | 0.110 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 7 | 2006 | 3810 | 0.110 |
Why?
|
| Protein Conformation | 1 | 2021 | 3968 | 0.110 |
Why?
|
| Microscopy, Confocal | 2 | 2014 | 1971 | 0.110 |
Why?
|
| Ubiquitination | 2 | 2019 | 1007 | 0.110 |
Why?
|
| DNA Primers | 4 | 2006 | 2820 | 0.110 |
Why?
|
| Escherichia coli | 6 | 2006 | 4217 | 0.100 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2006 | 687 | 0.100 |
Why?
|
| Point Mutation | 1 | 2017 | 1595 | 0.100 |
Why?
|
| Calcium | 1 | 2005 | 5722 | 0.100 |
Why?
|
| Cell Line, Transformed | 1 | 2013 | 866 | 0.100 |
Why?
|
| Genetic Loci | 1 | 2021 | 2632 | 0.100 |
Why?
|
| Fimbriae, Bacterial | 1 | 2012 | 138 | 0.100 |
Why?
|
| Epitopes | 4 | 1998 | 2503 | 0.100 |
Why?
|
| Galactosyltransferases | 1 | 1993 | 276 | 0.100 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 1995 | 563 | 0.100 |
Why?
|
| DNA, Bacterial | 5 | 2000 | 1479 | 0.090 |
Why?
|
| Immunotoxins | 1 | 1992 | 175 | 0.090 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 2 | 2003 | 221 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 3 | 2006 | 2645 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 4 | 2003 | 6075 | 0.090 |
Why?
|
| Immunity, Maternally-Acquired | 3 | 1995 | 111 | 0.090 |
Why?
|
| Dynamins | 1 | 2011 | 139 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2008 | 3779 | 0.090 |
Why?
|
| Fibronectins | 1 | 2013 | 723 | 0.090 |
Why?
|
| Chromosome Deletion | 1 | 1994 | 1386 | 0.090 |
Why?
|
| Premedication | 1 | 1990 | 246 | 0.090 |
Why?
|
| Disease Susceptibility | 3 | 2008 | 1787 | 0.080 |
Why?
|
| Electrophoretic Mobility Shift Assay | 2 | 2008 | 293 | 0.080 |
Why?
|
| Immunity | 1 | 1995 | 996 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2008 | 4576 | 0.080 |
Why?
|
| Pneumococcal Infections | 2 | 2005 | 501 | 0.080 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2006 | 1844 | 0.080 |
Why?
|
| DNA Transposable Elements | 6 | 1994 | 755 | 0.080 |
Why?
|
| Papio | 2 | 2001 | 669 | 0.080 |
Why?
|
| Carbohydrate Conformation | 5 | 1991 | 206 | 0.080 |
Why?
|
| Gene Expression Profiling | 4 | 2009 | 9420 | 0.080 |
Why?
|
| Immunodiffusion | 5 | 1996 | 141 | 0.080 |
Why?
|
| Genome, Bacterial | 2 | 2005 | 783 | 0.080 |
Why?
|
| Chromosome Mapping | 4 | 1996 | 4615 | 0.080 |
Why?
|
| Transcription Factors | 1 | 2008 | 12130 | 0.080 |
Why?
|
| Macrophage-1 Antigen | 2 | 2003 | 285 | 0.080 |
Why?
|
| Molecular Weight | 4 | 1998 | 2186 | 0.080 |
Why?
|
| Complement Pathway, Classical | 2 | 1999 | 91 | 0.080 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 1756 | 0.080 |
Why?
|
| Indicators and Reagents | 3 | 2001 | 462 | 0.080 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2014 | 1936 | 0.080 |
Why?
|
| Genetic Complementation Test | 2 | 2007 | 555 | 0.080 |
Why?
|
| Streptococcus pneumoniae | 3 | 2005 | 730 | 0.070 |
Why?
|
| Skin Diseases | 1 | 1996 | 1094 | 0.070 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1987 | 340 | 0.070 |
Why?
|
| Carbohydrate Metabolism | 1 | 2008 | 263 | 0.070 |
Why?
|
| Sequence Analysis | 2 | 2000 | 240 | 0.070 |
Why?
|
| Kinetics | 3 | 2003 | 6374 | 0.070 |
Why?
|
| Adenosine A3 Receptor Antagonists | 1 | 2006 | 2 | 0.070 |
Why?
|
| HeLa Cells | 1 | 2013 | 3094 | 0.070 |
Why?
|
| Infant, Newborn | 5 | 2006 | 26202 | 0.070 |
Why?
|
| Immunity, Innate | 3 | 2006 | 3066 | 0.070 |
Why?
|
| Medical Staff, Hospital | 1 | 1990 | 601 | 0.070 |
Why?
|
| Interleukin-6 | 2 | 2006 | 3208 | 0.070 |
Why?
|
| Octoxynol | 1 | 2006 | 77 | 0.070 |
Why?
|
| Lipopeptides | 1 | 2006 | 71 | 0.070 |
Why?
|
| N-Acetylneuraminic Acid | 4 | 1996 | 174 | 0.070 |
Why?
|
| Genes, Reporter | 2 | 2001 | 1529 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 5 | 2024 | 22174 | 0.060 |
Why?
|
| Female | 27 | 2018 | 392705 | 0.060 |
Why?
|
| Magnetic Resonance Spectroscopy | 4 | 2001 | 3769 | 0.060 |
Why?
|
| I-kappa B Proteins | 1 | 2006 | 211 | 0.060 |
Why?
|
| Leukocytes | 2 | 2008 | 2026 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2006 | 1741 | 0.060 |
Why?
|
| Interferon Inducers | 1 | 2004 | 25 | 0.060 |
Why?
|
| Complement Inactivator Proteins | 1 | 2004 | 74 | 0.060 |
Why?
|
| DNA Fragmentation | 1 | 2005 | 237 | 0.060 |
Why?
|
| Disease Models, Animal | 5 | 2024 | 18255 | 0.060 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2006 | 177 | 0.060 |
Why?
|
| Chromatography, Affinity | 1 | 2006 | 532 | 0.060 |
Why?
|
| Microscopy, Electron | 3 | 1997 | 2561 | 0.060 |
Why?
|
| Ligands | 2 | 2004 | 3272 | 0.060 |
Why?
|
| Complement Factor H | 1 | 2004 | 110 | 0.060 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2005 | 613 | 0.060 |
Why?
|
| Adenosine Deaminase | 1 | 2006 | 251 | 0.060 |
Why?
|
| Blood Bactericidal Activity | 2 | 1996 | 124 | 0.060 |
Why?
|
| Integrin alphaXbeta2 | 1 | 2003 | 29 | 0.060 |
Why?
|
| Complement Factor B | 1 | 2003 | 57 | 0.060 |
Why?
|
| Boron Compounds | 1 | 2005 | 182 | 0.060 |
Why?
|
| Cell Membrane | 2 | 2004 | 3687 | 0.060 |
Why?
|
| Exocytosis | 1 | 2005 | 320 | 0.060 |
Why?
|
| Magnesium Chloride | 1 | 2003 | 30 | 0.050 |
Why?
|
| Hand | 1 | 2009 | 903 | 0.050 |
Why?
|
| Sequence Deletion | 2 | 2001 | 1494 | 0.050 |
Why?
|
| Macrophage Activation | 1 | 2006 | 553 | 0.050 |
Why?
|
| Immune Sera | 3 | 1994 | 606 | 0.050 |
Why?
|
| Infection Control | 1 | 1990 | 982 | 0.050 |
Why?
|
| Permeability | 1 | 2005 | 723 | 0.050 |
Why?
|
| Pneumonia | 1 | 2015 | 2143 | 0.050 |
Why?
|
| Cations, Divalent | 1 | 2003 | 168 | 0.050 |
Why?
|
| Blotting, Southern | 3 | 1992 | 777 | 0.050 |
Why?
|
| Serum | 1 | 2003 | 209 | 0.050 |
Why?
|
| Cyclic AMP | 1 | 2006 | 1463 | 0.050 |
Why?
|
| Shock, Septic | 1 | 2009 | 768 | 0.050 |
Why?
|
| Liposomes | 1 | 2006 | 783 | 0.050 |
Why?
|
| Diagnosis, Differential | 2 | 2015 | 12973 | 0.050 |
Why?
|
| Immunity, Mucosal | 1 | 2005 | 483 | 0.050 |
Why?
|
| Adenosine | 1 | 2006 | 808 | 0.050 |
Why?
|
| Animals, Newborn | 3 | 1995 | 2677 | 0.050 |
Why?
|
| Intercellular Junctions | 1 | 2001 | 195 | 0.050 |
Why?
|
| Protein Folding | 1 | 2005 | 870 | 0.050 |
Why?
|
| Oligopeptides | 1 | 2006 | 1187 | 0.050 |
Why?
|
| Molecular Mimicry | 1 | 2001 | 213 | 0.050 |
Why?
|
| Cytoplasm | 1 | 2005 | 1510 | 0.040 |
Why?
|
| Phenotype | 4 | 2011 | 16592 | 0.040 |
Why?
|
| Twins, Monozygotic | 1 | 2022 | 470 | 0.040 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2001 | 242 | 0.040 |
Why?
|
| Peritoneum | 1 | 2001 | 225 | 0.040 |
Why?
|
| Acetylglucosaminidase | 1 | 2000 | 66 | 0.040 |
Why?
|
| Biopolymers | 1 | 2001 | 184 | 0.040 |
Why?
|
| HL-60 Cells | 1 | 2000 | 363 | 0.040 |
Why?
|
| Collectins | 1 | 1999 | 18 | 0.040 |
Why?
|
| STAT3 Transcription Factor | 1 | 2024 | 871 | 0.040 |
Why?
|
| Gene Deletion | 3 | 2009 | 2665 | 0.040 |
Why?
|
| Transduction, Genetic | 2 | 1994 | 903 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 1246 | 0.040 |
Why?
|
| Male | 11 | 2018 | 360846 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2006 | 1989 | 0.040 |
Why?
|
| Mannans | 1 | 1999 | 58 | 0.040 |
Why?
|
| Blood Proteins | 1 | 2004 | 1173 | 0.040 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2000 | 353 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 2005 | 1134 | 0.040 |
Why?
|
| Receptors, Adrenergic | 1 | 1979 | 155 | 0.040 |
Why?
|
| Glycoconjugates | 1 | 1999 | 88 | 0.040 |
Why?
|
| General Surgery | 1 | 1990 | 1692 | 0.040 |
Why?
|
| Bacterial Infections | 2 | 2006 | 1391 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2006 | 3792 | 0.040 |
Why?
|
| Luminescent Proteins | 1 | 2001 | 837 | 0.040 |
Why?
|
| Neurons | 1 | 2018 | 9463 | 0.040 |
Why?
|
| Granulocytes | 1 | 2000 | 551 | 0.040 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1979 | 242 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2006 | 5035 | 0.040 |
Why?
|
| Adult | 12 | 2009 | 221210 | 0.040 |
Why?
|
| Mice, Inbred Strains | 2 | 2005 | 1762 | 0.040 |
Why?
|
| Transcription, Genetic | 2 | 2005 | 7593 | 0.040 |
Why?
|
| Immunization | 2 | 1994 | 1227 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2006 | 1974 | 0.040 |
Why?
|
| Cost of Illness | 1 | 2008 | 1937 | 0.040 |
Why?
|
| Adrenergic beta-Agonists | 1 | 1979 | 345 | 0.040 |
Why?
|
| Genetic Vectors | 2 | 1998 | 3396 | 0.040 |
Why?
|
| Solubility | 1 | 1999 | 1091 | 0.040 |
Why?
|
| Diterpenes | 1 | 2018 | 171 | 0.040 |
Why?
|
| Lectins | 1 | 1999 | 491 | 0.040 |
Why?
|
| Caspase 1 | 1 | 2018 | 225 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2008 | 3113 | 0.040 |
Why?
|
| Artificial Gene Fusion | 1 | 1997 | 56 | 0.040 |
Why?
|
| Genetic Variation | 3 | 2005 | 6567 | 0.040 |
Why?
|
| Drug Utilization | 3 | 1993 | 1188 | 0.040 |
Why?
|
| Chromatography, Thin Layer | 1 | 1997 | 213 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2004 | 2203 | 0.030 |
Why?
|
| beta-Galactosidase | 2 | 1990 | 574 | 0.030 |
Why?
|
| Cytoskeleton | 1 | 2001 | 1170 | 0.030 |
Why?
|
| TRPV Cation Channels | 1 | 2018 | 244 | 0.030 |
Why?
|
| Endopeptidases | 1 | 2000 | 774 | 0.030 |
Why?
|
| Skin | 2 | 2018 | 4484 | 0.030 |
Why?
|
| Immunity, Active | 1 | 1995 | 58 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2001 | 2065 | 0.030 |
Why?
|
| Galactose | 1 | 1997 | 297 | 0.030 |
Why?
|
| Child | 5 | 2015 | 80158 | 0.030 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2018 | 323 | 0.030 |
Why?
|
| Sequence Alignment | 2 | 2005 | 2180 | 0.030 |
Why?
|
| Binding, Competitive | 3 | 1989 | 1141 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2012 | 16990 | 0.030 |
Why?
|
| Cytidine Triphosphate | 1 | 1994 | 17 | 0.030 |
Why?
|
| Acute Disease | 1 | 2006 | 7237 | 0.030 |
Why?
|
| Infant | 5 | 2022 | 36193 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2006 | 2688 | 0.030 |
Why?
|
| Monosaccharides | 1 | 1995 | 68 | 0.030 |
Why?
|
| Biological Transport, Active | 1 | 1995 | 328 | 0.030 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2018 | 237 | 0.030 |
Why?
|
| Health Care Costs | 1 | 2008 | 3242 | 0.030 |
Why?
|
| Genes, Synthetic | 1 | 1994 | 88 | 0.030 |
Why?
|
| Neisseria meningitidis | 1 | 1994 | 108 | 0.030 |
Why?
|
| Flow Cytometry | 2 | 2003 | 5870 | 0.030 |
Why?
|
| Immune Evasion | 1 | 2017 | 363 | 0.030 |
Why?
|
| Immunization Schedule | 1 | 1995 | 227 | 0.030 |
Why?
|
| Connective Tissue Diseases | 1 | 1997 | 285 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 10766 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2011 | 7391 | 0.030 |
Why?
|
| Drosophila Proteins | 1 | 2003 | 1699 | 0.030 |
Why?
|
| Restriction Mapping | 1 | 1994 | 851 | 0.030 |
Why?
|
| Time Factors | 3 | 2006 | 39969 | 0.030 |
Why?
|
| Receptors, Complement 3b | 1 | 1993 | 135 | 0.030 |
Why?
|
| Developing Countries | 1 | 2006 | 2885 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2019 | 14417 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 2024 | 3032 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2001 | 3733 | 0.030 |
Why?
|
| Fibrinogen | 1 | 1996 | 888 | 0.030 |
Why?
|
| Phylogeny | 3 | 2005 | 2811 | 0.030 |
Why?
|
| Antibody Affinity | 2 | 1996 | 246 | 0.030 |
Why?
|
| Drug Prescriptions | 2 | 1993 | 1670 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2001 | 2425 | 0.030 |
Why?
|
| Anticonvulsants | 1 | 2022 | 1906 | 0.030 |
Why?
|
| Neuraminidase | 1 | 1992 | 196 | 0.030 |
Why?
|
| Pharmacy Service, Hospital | 1 | 1993 | 134 | 0.020 |
Why?
|
| Mitochondria | 1 | 2005 | 3624 | 0.020 |
Why?
|
| Immunotherapy, Active | 1 | 1992 | 59 | 0.020 |
Why?
|
| Immunization, Passive | 2 | 1992 | 616 | 0.020 |
Why?
|
| Binding Sites, Antibody | 2 | 1989 | 337 | 0.020 |
Why?
|
| Adolescent | 4 | 2015 | 88326 | 0.020 |
Why?
|
| Collagen | 1 | 1999 | 2638 | 0.020 |
Why?
|
| Cefoxitin | 1 | 1990 | 35 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 1997 | 976 | 0.020 |
Why?
|
| Transfection | 1 | 1998 | 5774 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2006 | 10451 | 0.020 |
Why?
|
| Reminder Systems | 1 | 1993 | 388 | 0.020 |
Why?
|
| Seizures | 1 | 2022 | 2957 | 0.020 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1989 | 201 | 0.020 |
Why?
|
| Vaccines, Synthetic | 1 | 1992 | 616 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2007 | 20100 | 0.020 |
Why?
|
| Pain | 2 | 2018 | 5073 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 1996 | 6131 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1993 | 2748 | 0.020 |
Why?
|
| Acids | 1 | 2009 | 125 | 0.020 |
Why?
|
| Prevalence | 1 | 2006 | 15733 | 0.020 |
Why?
|
| Genotype | 1 | 2023 | 12990 | 0.020 |
Why?
|
| Gene Expression | 2 | 2005 | 7581 | 0.020 |
Why?
|
| Morphogenesis | 1 | 1992 | 741 | 0.020 |
Why?
|
| Methylation | 1 | 1991 | 1084 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1989 | 1302 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2000 | 9542 | 0.020 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 1989 | 445 | 0.020 |
Why?
|
| Erythema | 1 | 2009 | 262 | 0.020 |
Why?
|
| Antibody Formation | 1 | 1992 | 1395 | 0.020 |
Why?
|
| Cross Reactions | 1 | 1989 | 817 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 1999 | 5112 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 1999 | 4176 | 0.020 |
Why?
|
| Absenteeism | 1 | 2008 | 247 | 0.020 |
Why?
|
| Immunoblotting | 1 | 1989 | 1646 | 0.020 |
Why?
|
| Molecular Structure | 1 | 1990 | 1880 | 0.020 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2005 | 68 | 0.020 |
Why?
|
| Antigen-Antibody Complex | 1 | 1987 | 510 | 0.020 |
Why?
|
| Flagellin | 1 | 2006 | 124 | 0.020 |
Why?
|
| Vaccination | 2 | 1995 | 3384 | 0.020 |
Why?
|
| Polydeoxyribonucleotides | 1 | 2006 | 136 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1989 | 2467 | 0.020 |
Why?
|
| Drug Costs | 1 | 1993 | 1183 | 0.020 |
Why?
|
| Boston | 2 | 2015 | 9327 | 0.020 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2005 | 145 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2006 | 779 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 2 | 2005 | 4740 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 1991 | 4111 | 0.010 |
Why?
|
| Hypotension | 1 | 2009 | 879 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2001 | 11904 | 0.010 |
Why?
|
| Health Services | 1 | 2008 | 752 | 0.010 |
Why?
|
| Patients | 1 | 1989 | 907 | 0.010 |
Why?
|
| Nasopharynx | 1 | 2005 | 401 | 0.010 |
Why?
|
| Caspases | 1 | 2005 | 879 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2015 | 10090 | 0.010 |
Why?
|
| Critical Care | 1 | 2015 | 2697 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1987 | 3076 | 0.010 |
Why?
|
| Macrophages, Peritoneal | 1 | 2003 | 238 | 0.010 |
Why?
|
| Immunotherapy, Adoptive | 1 | 1992 | 1469 | 0.010 |
Why?
|
| Cesarean Section | 1 | 1990 | 1398 | 0.010 |
Why?
|
| Stress, Physiological | 1 | 2009 | 1403 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 2003 | 915 | 0.010 |
Why?
|
| Soft Tissue Infections | 1 | 2003 | 168 | 0.010 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2003 | 347 | 0.010 |
Why?
|
| Models, Biological | 1 | 1997 | 9469 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 2005 | 1519 | 0.010 |
Why?
|
| Dihydroalprenolol | 1 | 1979 | 8 | 0.010 |
Why?
|
| Rana pipiens | 1 | 1979 | 64 | 0.010 |
Why?
|
| Anura | 1 | 1979 | 80 | 0.010 |
Why?
|
| Guanine Nucleotides | 1 | 1979 | 55 | 0.010 |
Why?
|
| Rats | 2 | 1993 | 23741 | 0.010 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2003 | 579 | 0.010 |
Why?
|
| Cricetinae | 1 | 2003 | 2423 | 0.010 |
Why?
|
| Isoproterenol | 1 | 1979 | 395 | 0.010 |
Why?
|
| Species Specificity | 1 | 2002 | 2414 | 0.010 |
Why?
|
| Precipitin Tests | 2 | 1991 | 813 | 0.010 |
Why?
|
| Erythrocyte Membrane | 1 | 1979 | 439 | 0.010 |
Why?
|
| Pregnancy | 2 | 1999 | 29890 | 0.010 |
Why?
|
| United States | 1 | 2006 | 72340 | 0.010 |
Why?
|
| Inpatients | 1 | 1989 | 2548 | 0.010 |
Why?
|
| Biological Evolution | 1 | 2002 | 1071 | 0.010 |
Why?
|
| Transformation, Bacterial | 1 | 1996 | 76 | 0.010 |
Why?
|
| Immunotherapy | 1 | 1992 | 4652 | 0.010 |
Why?
|
| Hospitals | 1 | 1988 | 3883 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1996 | 1060 | 0.010 |
Why?
|
| Safety | 1 | 1999 | 1149 | 0.010 |
Why?
|
| Hospital Bed Capacity, 300 to 499 | 1 | 1993 | 55 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 1979 | 1241 | 0.010 |
Why?
|
| Tobramycin | 1 | 1993 | 65 | 0.010 |
Why?
|
| Immunoglobulin A | 1 | 1996 | 978 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 1998 | 58984 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1996 | 1351 | 0.010 |
Why?
|
| Forms and Records Control | 1 | 1993 | 158 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2015 | 42232 | 0.010 |
Why?
|
| Rhamnose | 1 | 1991 | 18 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 1996 | 1526 | 0.010 |
Why?
|
| Health Services Misuse | 1 | 1993 | 244 | 0.010 |
Why?
|
| Hemolysin Proteins | 1 | 1990 | 113 | 0.010 |
Why?
|
| Penicillins | 1 | 1992 | 402 | 0.010 |
Why?
|
| Sepsis | 1 | 2003 | 2585 | 0.000 |
Why?
|
| Drug Information Services | 1 | 1988 | 51 | 0.000 |
Why?
|
| Hospitals, Teaching | 1 | 1993 | 1156 | 0.000 |
Why?
|
| Vaccines | 1 | 1996 | 844 | 0.000 |
Why?
|
| Cefazolin | 1 | 1988 | 94 | 0.000 |
Why?
|
| Education, Medical, Continuing | 1 | 1993 | 823 | 0.000 |
Why?
|
| Information Systems | 1 | 1989 | 396 | 0.000 |
Why?
|
| DNA, Recombinant | 1 | 1987 | 455 | 0.000 |
Why?
|
| Metronidazole | 1 | 1988 | 232 | 0.000 |
Why?
|
| Clone Cells | 1 | 1990 | 1659 | 0.000 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1987 | 1058 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2015 | 80647 | 0.000 |
Why?
|
| Chemical Precipitation | 1 | 1985 | 175 | 0.000 |
Why?
|
| Cost Control | 1 | 1988 | 628 | 0.000 |
Why?
|
| Middle Aged | 2 | 1998 | 220921 | 0.000 |
Why?
|
| Aged | 1 | 1998 | 169310 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2009 | 20568 | 0.000 |
Why?
|
| Fever | 1 | 1989 | 1618 | 0.000 |
Why?
|
| Drug Administration Schedule | 1 | 1989 | 4853 | 0.000 |
Why?
|
| Drug Therapy, Combination | 1 | 1989 | 6312 | 0.000 |
Why?
|
| Prognosis | 1 | 1989 | 29629 | 0.000 |
Why?
|